期刊文献+

HE4在卵巢上皮性肿瘤组织中的表达

Expression of HE4 in Epithelial Ovarian Tumors
下载PDF
导出
摘要 目的通过检测HE4在卵巢上皮性恶性肿瘤、卵巢良性肿瘤、异位子宫内膜、正常内膜中的表达,把HE4作为一个肿瘤标记物,来鉴别盆腔肿物性质提供诊断依据。方法整群选取内蒙古人民医院2012年7月—2014年7月收治的167例手术患者,通过病理确诊:其中子宫内膜异位症的60例,卵巢良性肿瘤组织标本30例,正常内膜组织的因子宫病变而进行子宫全切术的患者30例,上皮性卵巢癌47例。采用免疫组化实验方法对各组石蜡切片进行化学染色,并进行对各组标本染色结果的染色强度进行评价,同时应用m Igae-or-plus对染色切片中的阳性部分测量其平均灰度值(mean IOD),并分析HE4在各组中的表达情况。结果子宫内膜异位症、卵巢上皮性恶性肿瘤、正常内膜中均有HE4的表达,HE4在卵巢良性肿瘤中的表达呈弱阳性或者阴性表达。HE4的表达在卵巢上皮性恶性肿瘤、子宫异位内膜、正常内膜、卵巢良性肿瘤中表达呈逐级下降趋势,HE4在四种不同组织中的表达的mean IOD值差异有统计学意义(P<0.05),而且进行两两组间比较均差异有统计学意义(P<0.05)。结论 1HE4在卵巢上皮性恶性肿瘤、子宫内膜异位症、正常内膜、卵巢良性肿瘤中的表达呈现逐级下降趋势,通过探索性研究,HE4可能作为一个良好的卵巢肿瘤标记物,有助于来鉴别盆腔肿物性质提供诊断依据;也表明HE4对肿瘤的发生、侵袭、转移、预后等发挥着重要作用。 Objective To detect the expression of HE4, a tumor marker, in patients with malignant epithelial ovarian cancer, benign ovarian tumor, endometriosis and normal endometrium so as to provide a diagnostic base for the identification of pelvic tumor. Methods In this study, 167 tissue specimens are from the Department of Pathology, Inner Mongolia People's Hospital, from July 2012 to July 2014. Totally 60 endometriosis samples were investigated as the experimental group, the benign ovarian tumor tissue samples from 30 cases and normal endometrium tissue samples from 30 cases underwent hysterectomy due to uterine lesions were set as the negative control respectively, and 47 samples of epithelial ovarian cancer as the positive control group. The expression of HE4 was examined by immunohistochemical staining between experimental group and control group. The expression intensity of HE4 was estimated by the microscope. The mean IOD of positive expression rates of HE4 were determined by m Igae-or-plus. The expression of HE4 in the groups was analyzed. Results Endometriosis, malignant epithelial ovarian tumor and normal endometrium had the distinct expression of HE4. The expression of HE4 was weakly positive or negative in benign ovarian tumor. The expression of HE4 showed a step-down trend in the malignant epithelial ovarian tumor, endometriosis, normal endometrium and benign ovarian tumor, and the mean IOD value of HE4 expression in the four different tissues had significant difference(P〈0.05), and pairwise comparisons were statistically significant(P〈0.05). Conclusion The expression of HE4 showed a step-down trend in the malignant epithelial ovarian tumor, endometriosis, normal endometrium and benign ovarian tumor. The study indicated that HE4 may be a good epithelial ovarian tumor marker, which provides diagnostic basis for identifying the nature of pelvic tumor; and plays an important role in the oncogenesis, invasion, metastasis, and outcome of the tumor.
出处 《中外医疗》 2016年第8期15-17,21,共4页 China & Foreign Medical Treatment
关键词 HE4 卵巢肿瘤 子宫内膜异位症 免疫组化 HE4 Ovarian tumor Endometriosis Immunohistochemistry
  • 相关文献

参考文献10

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 2Rafael Molina,Jose M.Escudero,Jose M.Augé,et al.HE4a novel tumour marker for ovarian cancer:comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases[J].Tumour Biol,2011,32(6):1087-1095.
  • 3Galgano MT,Hampton GM,Frierson HF Jr.Comprehensive analysis of HE4 expression in normal and malignant human tissues[J].Modern Pathology,2006,19(6):847-853.
  • 4Drapkin R,Lin Y,Mok SC,et al.Human epididymis protein4(HE4)is a secreted glycoprotein that is over ex-pressed byserous and endometrioid ovarian carcinomas[J].Cancer Res,2005,65(6):2162-2169.
  • 5陈颖,张岩,蒋宏颉.HE4 mRNA在卵巢癌中的表达及临床意义的研究[J].中国误诊学杂志,2010,10(23):5548-5551. 被引量:1
  • 6Partheen K,Kristjansdottir B,Sundfeldt K.Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass[J].J Gynecol Oncol,2011,22(4):244-252.
  • 7Bolstad N,ijordsbakken M,Nustad K,et al.Human epididymis protein 4 reference limits and natural variation in a Nordic reference population[J].Tumour Biol,2012,33(1):141-148.
  • 8Chen WT,Gao X,Han XD,et al.HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer[J].Asian Pac J Cancer Prev,2014,15(1):101-105.
  • 9Gislefoss RE,Langseth H,Bolstad N,et al.HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer:Investigations in Prediagnostic Specimens From the Janus Serumbank[J].Int J Gynecol Cancer,2015,25(9):1608-1615.
  • 10Wilailak S,Chan KK,Chen CA,et al.Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4,menopausal status,and ultrasound findings[J].J Gynecol Oncol,2015,26(1):46-53.

二级参考文献7

  • 1Badgwell D, Bast RC Jr. Early detection of ovarian cancer[J]. Dis Markers, 2007, 23(5 6):397- 410.
  • 2Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues [J]. Mod Pathol, 2006,19(6) :847-853.
  • 3Yurkovetsky ZR, Linkov FY, Malehorn ED, etal. Multiple biomarker panels for early detection of ovarian cancer[J]. Future Oncol, 2006, 2(6):733-741.
  • 4Maiorana A, Cicerone C, Niceta M, et al. Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis [J]. Int J Biol Markers, 2007, 22(3) :200- 202.
  • 5Hagiwara K, Kikuchi T, Endo Y, et al. Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif[J]. J Immunol,2003,170(4):1973- 1979.
  • 6Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J]. Gynecol Oneol, 2008,108 (2) : 402- 408.
  • 7陈颖,郑华川,赵雨杰,辛彦.Early Diagnosis of Epithelial Ovarian Cancer with cDNA Microarry[J].Chinese Journal of Cancer Research,2008,20(2):110-114. 被引量:1

共引文献1252

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部